NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email UK MP Mark Sewards launches an AI bot to answer constituents’ questions, sparking debate over usefulness, security risks, and political engagement.Read More